Gary A. Lyons
Director at Neurocrine Biosciences; Director at Travere Therapeutics; Director at Rigel Pharmaceuticals. Based in San Diego, California.
- Rank
- 4740th of 14,644
- Companies held
- 3
- Largest holding
- NBIX, 85.6% of total
- Latest SEC filing
- Aug 18, 2026
What the $22.6M is made of
Holdings counted
All filings on SEC.gov| Company | How held | Shares | Price | Value | Share of total | Reported |
|---|---|---|---|---|---|---|
| Neurocrine Biosciences NBIX Common Stock | Directly | 122,141 | $158.18 | $19.3M | 85.6% | Form 4, May 21, 2026 |
| Travere Therapeutics TVTX Common Stock | Directly | 61,500 | $48.00 | $3.0M | 13.1% | Form 4, Aug 18, 2026 |
| Rigel Pharmaceuticals RIGL Common Stock | Directly | 7,500 split-adjusted | $41.39 | $310K | 1.4% | Form 4, May 26, 2023 |
Share counts are the amounts Gary A. Lyons reported owning after each line of their latest filing for that company, adjusted for any later stock splits. Values use the latest price. Methodology.
Open-market trades, last 12 months
| Date | Trade | Company | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 18, 2026 | Sold | TVTX | 900 | $63.86 | $57K | View |
| Aug 18, 2026 | Sold | TVTX | 4,100 | $63.27 | $259K | View |
| Aug 17, 2026 | Sold | TVTX | 1,900 | $62.53 | $119K | View |
| Aug 17, 2026 | Sold | TVTX | 2,600 | $63.50 | $165K | View |
| Aug 17, 2026 | Sold | TVTX | 500 | $64.16 | $32K | View |
| Apr 14, 2026 | Sold | TVTX | 8,000 | $41.07 | $329K | View |
| Dec 3, 2025 | Sold | NBIX | 15,000 | $152.61 | $2.3M | View |
Nearby on the list
Full list| Rank | Name | Stock holdings |
|---|---|---|
| 4737 | Sara Yang Bosco Sr VP, Secy & Chf Leg Ofc, Emerson Electric. St. Louis, MO | $22.6M |
| 4738 | Michael Tabor 10% owner, iHeartMedia | $22.6M |
| 4739 | Gene H. Wickes Head of Benefits Deliv & Admin, Willis Towers Watson Public Limited | $22.6M |
| 4740 | Gary A. Lyons Director, Neurocrine Biosciences. San Diego, CA | $22.6M |
| 4741 | Nancy Quan Executive Vice President, The Coca-Cola. Atlanta, GA | $22.6M |
| 4742 | Ross Tennenbaum Chief Financial Officer, Dropbox. San Francisco, CA | $22.6M |
| 4743 | Gary A. Norcross Chairman and CEO, Fidelity National Information Services. Jacksonville, FL | $22.6M |
Other Neurocrine Biosciences insiders
All NBIX insiders- Kevin Charles Gorman$81.9MDirector. #1743 overall
- Kyle Gano$24.5MChief Executive Officer. #4448 overall
- Eric Benevich$10.6MChief Commercial Officer. #8405 overall
- Darin Lippoldt$9.0MChief Legal Officer. #9551 overall
- Eiry Roberts$8.1MChief Medical Officer. #9937 overall
- William H. Rastetter$6.9MDirector. #8516 overall
Questions
How much stock does Gary A. Lyons own?
Gary A. Lyons holds $22,582,688 in listed stock based on SEC filings and current prices, mostly Neurocrine Biosciences (NBIX). That ranks 4740th on the Stock Rich List.
Is this Gary A. Lyons's net worth?
No. It counts only listed shares reported on SEC Forms 3, 4 and 5. Cash, private companies, real estate, options and holdings that don't need to be reported are not included, so total net worth is likely different.
When did Gary A. Lyons last buy or sell stock?
The most recent open-market trade on file is a sale of 900 TVTX shares on Aug 18, 2026 at $63.86.